Transpek Industry Targets 15-20% FY27 Growth With Odisha Plan

Transpek Industry Limited has guided for 15-20% revenue growth in FY27, supported by a proposed ₹250 crore Odisha manufacturing project planned over five to six years and expanded research capacity. The proposal matters because Transpek Industry faces regulatory limits on expanding its Ekalbara facility and is evaluating a new site for future production.

What is Transpek Industry planning for FY27?

Transpek Industry is targeting 15-20% revenue growth in FY27 while pursuing capacity additions, research expansion and new product opportunities. Management has also stated an objective of doubling the business size over the next five years.

A central part of the plan is a greenfield manufacturing site in Odisha. Management has indicated an estimated project outlay of about ₹250 crore over five to six years, with an expected payback period of four to five years. The proposed facility is intended to support higher-volume acid chloride products and complex chemistries.

The company is also increasing its research focus. Its FY27 plan includes doubling the R&D team and associated infrastructure. At Ekalbara, a multipurpose pilot plant with four reaction streams is expected to be ready in six to seven months, according to management guidance.

Why is Transpek Industry considering an Odisha facility?

Transpek Industry is considering Odisha because regulatory permissions limit further expansion at its existing Ekalbara facility. The proposed greenfield site is being evaluated as a route to add manufacturing capacity beyond those constraints.

The Odisha government granted in-principle approval related to the company's land-acquisition interest, and Transpek Industry has been preparing a detailed feasibility report. On July 21, 2026, the Odisha State Level Single Window Clearance Authority approved a proposed specialty chemicals manufacturing facility in Ganjam district with an investment figure of ₹343 crore.

The figures of ₹250 crore and ₹343 crore appear in the available disclosures in different contexts. Management described approximately ₹250 crore of capex over five to six years during its investor communication, while the state-level clearance referenced a ₹343 crore proposed investment for the Ganjam specialty chemicals facility. The company has not presented the Expression of Interest as a final investment commitment.

How far has the Odisha project progressed?

The Odisha project has progressed through state-level clearance and an Expression of Interest, but it remains subject to Transpek Industry's Board approval and internal due diligence. The company submitted an EOI on July 22, 2026 for prospective investment in land and a manufacturing setup in Gopalpur, Odisha.

Transpek Industry explicitly clarified that submitting the EOI did not amount to a final investment decision. Management said a Board review was expected within 25-30 days, with a decision anticipated by the end of November if the approval process moved as planned.

If the Board approves the proposal, management indicated that required permissions could take three to four months. Production was described as potentially beginning 1.5 to two years after the approval and development process advances. These are management timelines rather than confirmed operating dates.

What does the expansion mean for investors and operations?

For investors, the Odisha plan provides a stated framework for Transpek Industry's growth ambitions, but the project remains conditional on Board approval, due diligence, land-related progress and statutory permissions. The company has not committed to construction in its EOI disclosure.

Operationally, the proposed facility is intended to ease the capacity constraint at Ekalbara and create room for products that need additional manufacturing scale. Management has linked the facility to high-volume acid chlorides and complex chemistries, while also discussing R&D activity in medical and aerospace polymers and niche domestic products.

The project also sits within Odisha's wider industrial approval programme. The state approved 23 industrial projects worth ₹4,573 crore, with projected employment of 22,873 jobs. Transpek Industry's proposed Ganjam specialty chemicals plant was reported as having an investment of ₹343 crore, although no company-specific employment figure was disclosed in the supplied information.

What other shareholder development has Transpek Industry disclosed?

Transpek Industry has declared a 200% dividend, with an ex-date of September 7, 2026. The supplied data does not provide the dividend amount per share, record date, payment date or the financial period to which the distribution relates.

The available information also states that a promoter acquisition increased total promoter shareholding from 69,001 shares, or 1.24%, to 204,005 shares, or 3.65%. No purchase price, acquisition date or identity of the acquiring promoter was included in the source material.

Conclusion

Transpek Industry's FY27 guidance combines a 15-20% revenue-growth target with a proposed Odisha expansion designed to address constraints at Ekalbara. The plan has moved beyond an initial expression of interest through state-level clearance, but it remains subject to internal approval, due diligence, land progress and regulatory permissions.

The next disclosed milestones are the Board's consideration of the Odisha proposal and further clarity on feasibility, approvals and construction timing. Investors can also track progress on the Ekalbara pilot plant, the planned doubling of R&D resources and execution against the FY27 revenue-growth guidance.